Parkinsonism

• FDA approval · 2026-08-03
  FDA Tentative Approval: CARBIDOPA AND LEVODOPA — Original Application (BIOCON PHARMA LIMITED)

  FDA tentative approval for a generic CARBIDOPA AND LEVODOPA product (BIOCON PHARMA LIMITED) under ANDA 220119.

• FDA approval · 2026-04-15
  FDA Approved: DATSCAN — Supplemental Application (Medi-Physics Inc. dba GE Healthcare.)

  This is a supplemental FDA approval for DATSCAN (ioflupane I-123) as a dopamine transporter imaging agent. It helps in evaluating suspected …

• FDA approval · 2022-09-21
  FDA Approved: CARBIDOPA-LEVODOPA — Original Application (Advagen Pharma Ltd.,)

  The FDA approved Advagen Pharma's original application for a generic carbidopa-levodopa product.

• FDA approval · 2015-11-05
  FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Dr. Reddy's Laboratories Inc)

  FDA approved Dr. Reddy's Laboratories' supplemental application for a generic carbidopa-levodopa product. This expands access to treatment f…

• FDA approval · 2012-11-28
  FDA Approved: BENZTROPINE MESYLATE — Original Application (Leading Pharma, LLC)

  FDA approved the original ANDA for benztropine mesylate from Leading Pharma, LLC, making a generic version available. It is indicated for th…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2009-07-28
  FDA Approved: BENZTROPINE MESYLATE — Original Application (Fresenius Kabi USA, LLC)

  FDA approved the original application for benztropine mesylate (generic) by Fresenius Kabi USA, LLC, expanding access to treatment for Parki…